ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer
European Respiratory Journal · 2023-10 · 62 (4) · 2300533
DOI: 10.1183/13993003.00533-2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 06.10.2023. Verfasst von Emma L O'Dowd und 32 weiteren Autor:innen. Beteiligte Einrichtung: Nottingham University Hospitals NHS Trust, Nottingham, UK. Hauptthemen laut MEDLINE: Lung Neoplasms, Practice Guidelines as Topic. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: European Respiratory Society.
Abstract (Originalsprache)
Background
Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted cancer screening programme. The imperative now is to ensure that implementation follows an evidence-based process that will ensure clinical and cost effectiveness. This European Respiratory Society (ERS) task force was formed to provide an expert consensus for the management of incidental findings which can be adapted and followed during implementation.
Methods
A multi-European society collaborative group was convened. 23 topics were identified, primarily from an ERS statement on lung cancer screening, and a systematic review of the literature was conducted according to ERS standards. Initial review of abstracts was completed and full text was provided to members of the group for each topic. Sections were edited and the final document approved by all members and the ERS Science Council.
Results
Nine topics considered most important and frequent were reviewed as standalone topics (interstitial lung abnormalities, emphysema, bronchiectasis, consolidation, coronary calcification, aortic valve disease, mediastinal mass, mediastinal lymph nodes and thyroid abnormalities). Other topics considered of lower importance or infrequent were grouped into generic categories, suitable for general statements.
Conclusions
This European collaborative group has produced an incidental findings statement that can be followed during lung cancer screening. It will ensure that an evidence-based approach is used for reporting and managing incidental findings, which will mean that harms are minimised and any programme is as cost-effective as possible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Nottingham University Hospitals NHS Trust, Nottingham, UK.
- University of Nottingham, Faculty of Medicine and Health Sciences, Nottingham, UK.
- Charles University, First Faculty of Medicine, Department of Tuberculosis and Respiratory Diseases, Prague, Czech Republic.
- Royal Brompton and Harefield NHS Foundation Trust, Radiology, London, UK.
- University of Heidelberg, Diagnostic and Interventional Radiology, Heidelberg, Germany.
- German Center for Lung Research DZL, Translational Lung Research Center TLRC, Heidelberg, Germany.
ORCID-Profile: Joanna Chorostowska-Wynimko, Herbert Decaluwe, Mina Gaga, Wouter van Geffen, Anna Kerpel-Fronius, Jan van Meerbeeck, Helmut Prosch, Marie-Pierre Revel, David R Baldwin
Förderung
- European Respiratory Society
Zitieren
APA
O'Dowd, E. L., Tietzova, I., Bartlett, E., Devaraj, A., Biederer, J., Brambilla, M., Brunelli, A., Chorostowska-Wynimko, J., Decaluwe, H., Deruysscher, D., De Wever, W., Donoghue, M., Fabre, A., Gaga, M., van Geffen, W., Hardavella, G., Kauczor, H. U., Kerpel-Fronius, A., van Meerbeeck, J., …, & Baldwin, D. R. (2023). ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. European Respiratory Journal, 62(4), 2300533. https://doi.org/10.1183/13993003.00533-2023
Vancouver
O'Dowd EL, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, et al. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. European Respiratory Journal. 2023;62(4):2300533. doi:10.1183/13993003.00533-2023
BibTeX
@article{ODowd2023,
author = {O'Dowd, Emma L and Tietzova, Ilona and Bartlett, Emily and Devaraj, Anand and Biederer, Jürgen and Brambilla, Marco and Brunelli, Alessandro and Chorostowska-Wynimko, Joanna and Decaluwe, Herbert and Deruysscher, Dirk and De Wever, Walter and Donoghue, Matthew and Fabre, Aurelie and Gaga, Mina and van Geffen, Wouter and Hardavella, Georgia and Kauczor, Hans-Ulrich and Kerpel-Fronius, Anna and van Meerbeeck, Jan and Nagavci, Blin and Nestle, Ursula and Novoa, Nuria and Prosch, Helmut and Prokop, Mathias and Putora, Paul Martin and Rawlinson, Janette and Revel, Marie-Pierre and Snoeckx, Annemiek and Veronesi, Giulia and Vliegenthart, Rozemarijn and Weckbach, Sabine and Blum, Torsten G and Baldwin, David R},
title = {ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer},
journal = {European Respiratory Journal},
year = {2023},
volume = {62},
number = {4},
pages = {2300533},
doi = {10.1183/13993003.00533-2023}
}
EUVIMED